Sarah Cannon Research Institute
Amber Woodward-Smith has a diverse work experience spanning over 15 years. Amber currently serves as the CFO at Sarah Cannon Research Institute since March 2019. Prior to this role, they held the position of CFO at CareNow from December 2014 to March 2019. Amber also has experience as the Director of Operations Finance at Fast Pace Medical Clinic from January 2013 to December 2014. Before that, they worked as a Business Analyst at Silvercare Solutions from July 2011 to January 2013. Earlier in their career, Amber held the role of Financial Analyst at The Little Clinic from December 2008 to July 2010, and Sr. Capital Financial Analyst at LifePoint Hospitals from June 2004 to August 2008.
Amber Woodward-Smith attended Belmont University from 2000 to 2004, where they obtained a Bachelor of Business Administration (BBA) degree in Accounting. Following this, they pursued further education at Belmont University from 2004 to 2005, acquiring a Master of Accountancy (MACC) degree in Accounting.
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.